Epilepsy Talk
Food or medications — which would you choose?
7 Comments
It’s heartbreaking, but all too common…
A patient calls their doctor after repeated seizures.
He had missed his medication for about a week. He had recently been laid off and lost insurance coverage.
He couldn’t afford to refill his eslicarbazepine acetate (Aptiom) prescription.
$56,000 a year for an unproven drug!
Leave a Comment
Getting the FDA to retract a decision, is like getting the toothpaste back in the tube, after it’s been squeezed out…
Whether it’s “yes” or “no,” there is no “maybe so”.
A good example is the new all star Alzheimer’s drug aducanumab.
Whether it’s “yes” or “no,” there is no “maybe so”.
Tags: $56000 a year, aducanumab, Alzheimer’s, efficiency, FDA, not proven, patients, risk, side-effects
Groundbreaking Report: A Giant Step for Epilepsy
6 Comments
In a special presentation from the Institute of Medicine (IOM), a groundbreaking report was released with 13 recommendations that the IOM designed to help improve care for all people with epilepsy…
About the author
Epilepsy Talk 